231 related articles for article (PubMed ID: 26429634)
1. Skin Cancer Screening in Germany. Documenting Melanoma Incidence and Mortality From 2008 to 2013.
Katalinic A; Eisemann N; Waldmann A
Dtsch Arztebl Int; 2015 Sep; 112(38):629-34. PubMed ID: 26429634
[TBL] [Abstract][Full Text] [Related]
2. Does skin cancer screening save lives? A detailed analysis of mortality time trends in Schleswig-Holstein and Germany.
Stang A; Jöckel KH
Cancer; 2016 Feb; 122(3):432-7. PubMed ID: 26480048
[TBL] [Abstract][Full Text] [Related]
3. [Incidence of melanoma and changes in stage-specific incidence after implementation of skin cancer screening in Schleswig-Holstein].
Eisemann N; Waldmann A; Katalinic A
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Jan; 57(1):77-83. PubMed ID: 24357176
[TBL] [Abstract][Full Text] [Related]
4. Melanoma mortality following skin cancer screening in Germany.
Boniol M; Autier P; Gandini S
BMJ Open; 2015 Sep; 5(9):e008158. PubMed ID: 26373399
[TBL] [Abstract][Full Text] [Related]
5. Does skin cancer screening save lives?: an observational study comparing trends in melanoma mortality in regions with and without screening.
Katalinic A; Waldmann A; Weinstock MA; Geller AC; Eisemann N; Greinert R; Volkmer B; Breitbart E
Cancer; 2012 Nov; 118(21):5395-402. PubMed ID: 22517033
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer).
Katalinic A; Kunze U; Schäfer T
Br J Dermatol; 2003 Dec; 149(6):1200-6. PubMed ID: 14674897
[TBL] [Abstract][Full Text] [Related]
7. Participation and health care provision of statutory skin cancer screening in Germany - a secondary data analysis.
Anastasiadou Z; Schäfer I; Siebert J; Günther W; Reusch M; Augustin M
J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):424-7. PubMed ID: 26856813
[TBL] [Abstract][Full Text] [Related]
8. Declining Bowel Cancer Incidence and Mortality in Germany.
Brenner H; Schrotz-King P; Holleczek B; Katalinic A; Hoffmeister M
Dtsch Arztebl Int; 2016 Feb; 113(7):101-6. PubMed ID: 26940777
[TBL] [Abstract][Full Text] [Related]
9. [Breast cancer mortality in women in the Schleswig-Holstein district 1981 to 1995].
Heitmann C; Bauer A; Hoffmann W; Kruse H
Gesundheitswesen; 2001 Jun; 63(6):383-91. PubMed ID: 11467221
[TBL] [Abstract][Full Text] [Related]
10. Systematic skin cancer screening in Northern Germany.
Breitbart EW; Waldmann A; Nolte S; Capellaro M; Greinert R; Volkmer B; Katalinic A
J Am Acad Dermatol; 2012 Feb; 66(2):201-11. PubMed ID: 22074699
[TBL] [Abstract][Full Text] [Related]
11. Observed and expected mortality in the German skin cancer screening pilot project SCREEN.
Eisemann N; Waldmann A; Holleczek B; Katalinic A
J Med Screen; 2018 Sep; 25(3):166-168. PubMed ID: 29169295
[TBL] [Abstract][Full Text] [Related]
12. The many unanswered questions related to the German skin cancer screening programme.
Stang A; Garbe C; Autier P; Jöckel KH
Eur J Cancer; 2016 Sep; 64():83-8. PubMed ID: 27371911
[TBL] [Abstract][Full Text] [Related]
13. [Malignant melanoma of the skin: does screening for cancer influence the incidence and mortality?].
Schubert A
Gesundheitswesen; 2012 Mar; 74(3):154-9. PubMed ID: 21305450
[TBL] [Abstract][Full Text] [Related]
14. Skin cancer rates in North Rhine-Westphalia, Germany before and after the introduction of the nationwide skin cancer screening program (2000-2015).
Stang A; Jöckel KH; Heidinger O
Eur J Epidemiol; 2018 Mar; 33(3):303-312. PubMed ID: 29294207
[TBL] [Abstract][Full Text] [Related]
15. Skin cancer screening participation and impact on melanoma incidence in Germany--an observational study on incidence trends in regions with and without population-based screening.
Waldmann A; Nolte S; Weinstock MA; Breitbart EW; Eisemann N; Geller AC; Greinert R; Volkmer B; Katalinic A
Br J Cancer; 2012 Feb; 106(5):970-4. PubMed ID: 22294187
[TBL] [Abstract][Full Text] [Related]
16. Development of a microsimulation of melanoma mortality for evaluating the effectiveness of population-based skin cancer screening.
Eisemann N; Waldmann A; Garbe C; Katalinic A
Med Decis Making; 2015 Feb; 35(2):243-54. PubMed ID: 25145574
[TBL] [Abstract][Full Text] [Related]
17. [Skin cancer screening in Germany: review after ten years].
Hübner J; Eisemann N; Brunßen A; Katalinic A
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 Dec; 61(12):1536-1543. PubMed ID: 30411137
[TBL] [Abstract][Full Text] [Related]
18. [Malignant melanoma of the skin as evidenced by epidemiological cancer registries in Germany -- incidence, clinical parameters, variations in recording].
Lehnert M; Eberle A; Hentschel S; Katalinic A; Kieschke J; Schmidtmann I; Schubert-Fritschle G; Stegmaier C; Hense HW
Gesundheitswesen; 2005 Oct; 67(10):729-35. PubMed ID: 16235142
[TBL] [Abstract][Full Text] [Related]
19. Trends in melanoma in the elderly in Denmark, 1980-2012.
Hoejberg L; Gad D; Gyldenkerne N; Bastholt L;
Acta Oncol; 2016; 55 Suppl 1():52-8. PubMed ID: 26785326
[TBL] [Abstract][Full Text] [Related]
20. Non-melanoma skin cancer incidence and impact of skin cancer screening on incidence.
Eisemann N; Waldmann A; Geller AC; Weinstock MA; Volkmer B; Greinert R; Breitbart EW; Katalinic A
J Invest Dermatol; 2014 Jan; 134(1):43-50. PubMed ID: 23877569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]